Recent advances in cancer metabolism: a technological perspective
Cancer: Tools for mapping malignant metabolism Researchers now have access to a rapidly growing number of tools for probing the metabolic abnormalities associated with tumor growth. Unrestrained growth puts special demands on cancer cells, and scientists have known for nearly a century that tumor me...
Main Authors: | Yun Pyo Kang, Nathan P. Ward, Gina M. DeNicola |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-04-01
|
Series: | Experimental and Molecular Medicine |
Online Access: | https://doi.org/10.1038/s12276-018-0027-z |
Similar Items
-
A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer
by: Chang Jiang, et al.
Published: (2022-08-01) -
Corrigendum to “A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer” [Redox Biol. 54 (2022) 102358]
by: Chang Jiang, et al.
Published: (2022-08-01) -
Dissecting the Crosstalk between NRF2 Signaling and Metabolic Processes in Cancer
by: Janine M. DeBlasi, et al.
Published: (2020-10-01) -
Correction: Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer
by: Yun Pyo Kang, et al.
Published: (2019-10-01) -
Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer
by: Yun Pyo Kang, et al.
Published: (2019-05-01)